GSK plc
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United …
Drug Manufacturers - General
GB, Brentford [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 0.76 | 60.22 | 59.77 | |
| Graham Fair Price | 75.49 | 4.44 | 2.53 | |
| PEG | -85.30 | 0.16 | -1.11 | |
| Price/Book | 12.19 | 9.94 | 8.86 | |
| Price/Cash Flow | 576.96 | 365.71 | 54.02 | |
| Prices/Earnings | -61.07 | 32.87 | 84.43 | |
| Price/Sales | 27.22 | 18.68 | 14.68 | |
| Price/FCF | 576.96 | 365.71 | 54.02 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 3.85 | 0.74 | 0.71 | |
| Operating Margin | 106.14 | 0.27 | 0.13 | |
| ROA | 201.38 | 0.02 | < 0.005 | |
| ROE | 0.03 | 0.08 | 188.21 | |
| ROIC | 0.04 | 0.05 | 37.37 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.01 | -0.14 | 89.91 | |
| Dividends QOQ | < 0.005 | < 0.005 | 115.57 | |
| EBIT QOQ | -0.46 | 0.88 | 92.29 | |
| EPS QOQ | -0.76 | 2.01 | 164.74 | |
| FCF QOQ | 0.28 | -0.83 | 200.27 | |
| Revenue QOQ | -0.01 | -0.09 | -633.82 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Positive
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 211.64 | 264.94 | 25.18 | |
| Days Sales Outstanding (DSO) | 82.75 | 89.12 | 7.70 | |
| Inventory Turnover | 0.43 | 0.34 | -20.12 | |
| Debt/Capitalization | 0.56 | 0.56 | 0.44 | |
| Quick Ratio | 0.60 | 0.57 | -3.96 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 3.29 | 3.40 | 3.37 | |
| Cash | 1.28 | 1.01 | -21.22 | |
| Capex | -0.19 | -0.14 | 28.32 | |
| Free Cash Flow | 0.54 | 0.09 | -82.87 | |
| Revenue | 1.99 | 1.81 | -8.84 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Bad
Fundamentals
Financial Health
06 - Financial Health ·
Bad